Table 1.
Reference population (n = 1226) | Child volunteers | Normotensive volunteers | Hypertensive subjects | Patient group 1* | Patient group 2* |
---|---|---|---|---|---|
N | 116 | 317 | 258 | 331 | 204 |
Age (median and range) | 13 (5–17) | 36 (18–73) | 48 (18–84) | 39 (18–77) | 50 (18–81) |
Gender (F/M) | 59/57 | 168/149 | 138/120 | 193/138 | 121/83 |
Validation population (n = 3888) | Patients with phaeochromocytoma | Patients without phaeochromocytoma |
---|---|---|
N | 558 | 3330 |
Age (median and range) | 44 (6–89) | 54 (4–96) |
Gender (F/M) | (277/281) | (1960/1367)† |
Group 1 represent patients tested because of an incidental mass found on imaging, an underlying germline mutation or a previous history of the tumour; patient group 2 represent patients tested because of signs and symptoms suggestive of phaeochromocytoma
For three patients there was no gender assignment